SBK Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
SBK Financial's ALNY Position: Q2 2026 in Review
SBK Financial sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 8 shares — an estimated $2.65K sold.
SBK Financial first reported a position in ALNY in Q1 2026 and held it in 1 quarter. The position peaked at $2.65K in Q1 2026. 797 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- SBK Financial reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- SBK Financial sold 8 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.65K.
- SBK Financial first reported a position in Alnylam Pharmaceuticals in Q1 2026 and held it in 1 quarter.
- SBK Financial's Alnylam Pharmaceuticals position peaked at $2.65K in Q1 2026.
- 797 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.